Cerevel Therapeutics
CERE
$42.31
Share price
0.17%
Change (1 day)
31.77%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) Fails to deliver data
Key failure to deliver metrics for Cerevel Therapeutics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $1.02 M
- Last year FTD volume: $56.29 M
Failures to deliver for Cerevel Therapeutics (CERE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cerevel Therapeutics (CERE) - since 2020
Volume in USD (price x number of shares), data since 2020Cerevel Therapeutics (CERE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.21 M | -98.05% |
| 2023 | $62.35 M | 289.39% |
| 2022 | $16.01 M | -39.91% |
| 2021 | $26.64 M | 1389.35% |
| 2020 | $1.78 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $83.89 M | $0.12 B | 🇺🇸 USA |
 Campbell Soup CPB | $34.75 M | $87.61 M | 🇺🇸 USA |
 Dow DOW | $10.74 M | $52.06 M | 🇺🇸 USA |
 Dupont De Nemours DD | $10.85 M | $78.23 M | 🇺🇸 USA |